Standout Papers

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized... 2011 2026 2016 2021 1.1k
  1. Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial (2011)
    Samuel A. Wells, Bruce G. Robinson et al. Journal of Clinical Oncology
  2. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease (2021)
    Robert Zeiser, Nicola Polverelli et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 32 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Thyroid Cancer
2024 Standout
Thyroid cancer
2023 Standout
14 intermediate papers

Works of Peter Langmuir being referenced

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011 Standout
A phase II trial of ZD6474 in patients with hereditary metastatic medullary thyroid cancer
2006

Author Peers

Author Last Decade Papers Cites
Peter Langmuir 1620 1811 370 1289 55 4.6k
David Boulware 906 1477 247 1538 122 5.3k
Alex McMillan 703 925 465 842 55 3.4k
Steinbjørn Hansen 3036 1700 1018 1489 88 5.5k
Diane Prager 3407 3429 203 1552 54 5.3k
David R. Shalinsky 1000 1679 187 2254 51 4.3k
Shenhong Wu 1652 2882 432 1422 96 5.3k
Pirow Bekker 1145 2901 518 2057 76 5.7k
Bijoyesh Mookerjee 2194 3611 522 4022 84 7.3k
Hans–Konrad Müller–Hermelink 742 1291 585 574 64 3.8k
Arturo Molina 4497 2486 807 1054 161 7.7k

All Works

Loading papers...

Rankless by CCL
2026